MedImmune, Trellis in RSV antibody deal

Trellis Bioscience Inc. (South San Francisco, Calif.) granted MedImmune LLC an exclusive, worldwide license to develop and commercialize antibodies against respiratory syncytial virus (RSV). The antib...